BHC.TO
Bausch Health Companies Inc
Price:  
6.88 
CAD
Volume:  
261,312.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BHC.TO EV/EBITDA

246.8%
Upside

As of 2026-07-15, the EV/EBITDA ratio of Bausch Health Companies Inc (BHC.TO) is 8.38. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BHC.TO's latest enterprise value is 30,251.91 mil CAD. BHC.TO's TTM EBITDA according to its financial statements is 3,609.00 mil CAD. Dividing these 2 quantities gives us the above BHC.TO EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 7.3x - 9.2x 8.4x
Forward P/E multiples 8.4x - 9.3x 8.6x
Fair Price 5.35 - 52.39 23.86
Upside -22.2% - 661.4% 246.8%
6.88 CAD
Stock Price
23.86 CAD
Fair Price

BHC.TO EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-07-13 5.90
2026-07-10 5.90
2026-07-09 5.90
2026-07-08 5.91
2026-07-07 5.91
2026-07-06 5.90
2026-07-03 5.91
2026-07-02 5.91
2026-06-30 5.91
2026-06-29 5.90
2026-06-26 5.90
2026-06-25 5.95
2026-06-24 5.92
2026-06-23 5.90
2026-06-22 5.88
2026-06-19 5.88
2026-06-18 5.89
2026-06-17 5.89
2026-06-16 5.91
2026-06-15 5.91
2026-06-12 5.92
2026-06-11 5.93
2026-06-10 5.93
2026-06-09 5.93
2026-06-08 5.92
2026-06-05 5.95
2026-06-04 5.93
2026-06-03 5.90
2026-06-02 5.91
2026-06-01 5.94
2026-05-29 5.94
2026-05-28 5.95
2026-05-27 5.95
2026-05-26 5.95
2026-05-25 5.96
2026-05-22 5.95
2026-05-21 5.95
2026-05-20 5.95
2026-05-19 5.94
2026-05-15 5.95
2026-05-14 5.95
2026-05-13 5.93
2026-05-12 5.94
2026-05-11 5.94
2026-05-08 5.98
2026-05-07 5.97
2026-05-06 5.96
2026-05-05 5.96
2026-05-04 5.95
2026-05-01 5.96